Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
January 26, 2024 09:04 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...